Addiction Medicine Updates

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study.An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing